Yuan Gao, Shengnan Wang, Lijun Sun, Bing Li, Hong Liu, Ren Bu, Changhai Su, Min Guo, Yang Liu, Lulu Zhao, Chao Gu, Xiaojia Li, Xiaorong Yuan, Qiwen Wang, Gang Li
The progression of chronic kidney diseases (CKD) is complex, influenced by a myriad of factors including gut microbiota. While emerging evidence suggests that gut microbiota can have beneficial effects in managing CKD, it is also recognized that dysbiosis may contribute to the progression of CKD and associated uremic complications. Our previous research has demonstrated the efficacy of lanthanum hydroxide in delaying kidney failure and preserving renal function. However, the role of lanthanum hydroxide in modulating gut microbiota in this context remains unclear...
April 2024: Pharmacology Research & Perspectives